Related Experiment Video
Updated: Jul 17, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
The PANACEA Project: a multinational model for digital health literacy in inflammatory bowel disease
Viviana Parra Izquierdo1,2, Beatriz Iade Vergara3, Marta Benner Machado4
1Department of Gastroenterology and Rheumatology, Hospital Internacional de Colombia, Bucaramanga, Colombia.
Background:
Inflammatory bowel disease (IBD) represents an increasing public health challenge in Latin America, where structural inequities and limited access to standardized education contribute to gaps in health literacy. Despite the recognized role of patient education in IBD care, region-wide, structured digital initiatives remain limited.
Objective:
To describe the implementation, reach, and educational performance of PANACEA (PANamerican Crohn's and Colitis Educational Approach), a multinational digital education program for patients with IBD and caregivers in Latin America.
Methods:
We conducted a multicenter observational descriptive study evaluating four consecutive PANACEA cohorts delivered between 2024 and 2025 through an asynchronous e-learning platform. Adults with IBD or caregivers voluntarily enrolled and completed standardized pre- and post-module knowledge assessments and satisfaction surveys. Program adherence, baseline characteristics, knowledge change, normalized learning gain, and user satisfaction were analyzed using descriptive statistics.
Results:
A total of 1366 participants from 15 Latin American countries completed baseline assessments (mean age 41.4 years; 80% female). Sustained adherence to the platform was 53.1%. Cohorts with intermediate baseline knowledge demonstrated improvements in program-specific knowledge assessments (absolute improvement 8-9 points; normalized gain 0.43-0.52), while cohorts with high baseline scores exhibited ceiling effects. Participants with lower baseline knowledge tended to demonstrate greater relative improvements in knowledge scores. Satisfaction exceeded 90% across content quality, usability, and perceived usefulness.
Conclusions:
This observational evaluation demonstrates that PANACEA is a feasible and scalable digital education model for IBD in Latin America, achieving broad regional reach, high user satisfaction, and improvements in program-specific knowledge scores, particularly among participants with lower baseline knowledge levels.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
